Physician
Southern Ohio Pathology Consultants INC
Southern Ohio Pathology Consultants INC was paid $2.66M by Medicaid between Jan 2018 and Dec 2024, across 111 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 67% of everything it billed.
33Billing provider infoSOUTHERN OHIO PATHOLOGY CONSULTANTS INC
CINCINNATI, OH 45220
CINCINNATI, OH 45220
33aNPI1831173202assigned 11/30/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.66M
24GClaims123,825
24DCodes billed111
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Ohio
Rank by total paid#2 of 90
Median peer was paid$23K
This provider vs. median118×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,032 | $308K | |
| 2019 | 12,528 | $379K | |
| 2020 | 10,702 | $365K | |
| 2021 | 12,314 | $395K | |
| 2022 | 13,027 | $447K | |
| 2023 | 8,765 | $311K | |
| 2024incomplete | 48,457 | $457K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 67% | 50,236 | 46,867 | $1.77M |
| 88307 | 14% | 6,611 | 6,192 | $377K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 7.4% | 3,051 | 2,978 | $197K |
| 85060 | 2.9% | 6,392 | 5,807 | $79K | |
| 88342 | 2.0% | 2,643 | 2,454 | $53K | |
| 88304 | 1.2% | 4,013 | 3,868 | $32K | |
| 84165 | 1.1% | 3,025 | 2,751 | $28K | |
| 88141 | <1% | 1,208 | 1,170 | $24K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,476 | 1,411 | $18K |
| 83020 | <1% | 1,192 | 1,163 | $15K | |
| 88187 | <1% | 209 | 190 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 486 | 479 | $5K |
99 more codes
| 88112 | <1% | 314 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 984 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 968 | $4K |
| 87625 | <1% | 127 | $4K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 12 | $3K |
| 88341 | <1% | 70 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,680 | $3K |
| 80076 | <1% | 1,265 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,662 | $2K |
| 82803 | <1% | 437 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,759 | $2K |
| 81001 | <1% | 2,007 | $2K | |
| 87070 | <1% | 378 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 62 | $1K |
| 84484 | <1% | 1,264 | $1K | |
| 83735 | <1% | 1,814 | $1K | |
| 85027 | <1% | 1,045 | $1K | |
| 87563 | <1% | 37 | $884.48 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 320 | $878.48 |
| 80069 | <1% | 781 | $735.46 | |
| 88189 | <1% | 14 | $676.16 | |
| 83880 | <1% | 459 | $571.90 | |
| 82962 | <1% | 976 | $560.56 | |
| 83605 | <1% | 977 | $555.20 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 154 | $538.77 |
| 82247 | <1% | 367 | $534.57 | |
| 84703 | <1% | 955 | $515.43 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 259 | $441.37 |
| 83690 | <1% | 1,215 | $406.20 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 905 | $403.29 |
| 81003 | <1% | 614 | $394.54 | |
| 82570 | <1% | 233 | $381.65 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 595 | $359.83 |
| 85390 | <1% | 13 | $353.55 | |
| 85730 | <1% | 335 | $319.96 | |
| 84145 | <1% | 190 | $295.58 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 455 | $276.95 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 214 | $213.84 |
| 86334 | <1% | 26 | $210.98 | |
| 86780 | <1% | 362 | $204.91 | |
| 87040 | <1% | 291 | $203.23 | |
| 87186 | <1% | 137 | $201.33 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 178 | $188.79 |
| 84156 | <1% | 130 | $182.85 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 297 | $173.16 |
| 80061 | Lipid panel | <1% | 497 | $164.98 |
| 85610 | <1% | 565 | $151.74 | |
| 84132 | <1% | 81 | $150.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 114 | $150.00 |
| 82565 | <1% | 194 | $145.08 | |
| 82330 | <1% | 128 | $131.20 | |
| 82077 | <1% | 554 | $128.48 | |
| 86850 | <1% | 379 | $123.25 | |
| 88311 | <1% | 16 | $113.70 | |
| 87481 | <1% | 245 | $96.04 | |
| 85014 | <1% | 114 | $87.60 | |
| 81025 | <1% | 489 | $85.61 | |
| 81002 | <1% | 44 | $84.94 | |
| 87430 | <1% | 314 | $84.05 | |
| 85018 | <1% | 96 | $76.20 | |
| 88312 | <1% | 17 | $75.23 | |
| 84100 | <1% | 132 | $72.90 | |
| 86901 | <1% | 510 | $72.06 | |
| 86900 | <1% | 511 | $72.06 | |
| 83615 | <1% | 205 | $71.37 | |
| 84460 | <1% | 148 | $71.06 | |
| 84450 | <1% | 147 | $69.36 | |
| 87077 | <1% | 229 | $52.26 | |
| 87340 | <1% | 144 | $44.69 | |
| 84520 | <1% | 106 | $43.54 | |
| 87205 | <1% | 282 | $43.19 | |
| 85379 | <1% | 115 | $40.72 | |
| 84550 | <1% | 189 | $39.16 | |
| 82550 | <1% | 49 | $37.41 | |
| 87641 | <1% | 15 | $30.41 | |
| 87660 | <1% | 52 | $19.20 | |
| 87480 | <1% | 53 | $18.00 | |
| 87510 | <1% | 52 | $18.00 | |
| 87081 | <1% | 40 | $17.07 | |
| 86140 | <1% | 86 | $15.16 | |
| 86702 | <1% | 55 | $13.52 | |
| 88720 | <1% | 117 | $11.50 | |
| 86762 | <1% | 75 | $10.79 | |
| 84439 | <1% | 98 | $10.52 | |
| 86701 | <1% | 25 | $8.89 | |
| 83550 | <1% | 61 | $8.74 | |
| 85652 | <1% | 27 | $2.70 | |
| 82728 | 0% | 49 | $0.00 | |
| 82746 | 0% | 45 | $0.00 | |
| 82607 | 0% | 82 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 116 | $0.00 |
| 82043 | 0% | 31 | $0.00 | |
| 84153 | 0% | 13 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 12 | $0.00 |
| 80179 | 0% | 69 | $0.00 | |
| 87210 | 0% | 25 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 38 | $0.00 |
| 80143 | 0% | 68 | $0.00 | |
| 83540 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPANKE, THOMAS (PRESIDENT)